Strategic Vision: A Global Pharma Company slide image

Strategic Vision: A Global Pharma Company

Progress on US Inhalation Pipeline Product (Market SizeĀ¹) Albuterol MDI Brovana AG Tiotropium DPI MDI 1 MDI 2 Formulation PK Study PD Study Filing Launched Launched in US Launched in US Tiotropium DPI is filed and under review PK Studies to commence shortly MDI 1 is filed MDI 3 MDI 4 PK Studies to commence shortly PK Studies to commence shortly MDI 5 DPI 1 DPI 2 1. IQVIA MAT Mar 2022 PK Studies to commence shortly PK Studies to commence shortly PK Studies to commence shortly Total Inhalation target market size of ~US$ 22.4 bn LUPIN 16
View entire presentation